Pharmaceuticals Are Rising: Why AstraZeneca Is Not In Trouble AZN
This morning pharmaceutical and medicine giant AstraZeneca ($AZN) announced an immediate interruption of the COVID-19 vaccine test during the Phase 3 study, after a participant in from the UK showed severe neurological symptoms of an unexplained disease. As a result, the company has discontinued the standard process in order to review the safety data first.…